Budapest, Hungary

Kalman Takacs


Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 92(Granted Patents)


Company Filing History:


Years Active: 1976-2006

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Kalman Takacs: Innovator in Pharmaceutical Chemistry

Introduction

Kalman Takacs is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work focuses on innovative compounds that address critical health issues.

Latest Patents

One of his latest patents is titled "Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same." This invention refers to novel propenecarboxylic acid amidoxime derivatives, including N-oxides, geometrical isomers, optical isomers, and pharmaceutically suitable acid addition salts. The novel compounds are designed for the treatment of conditions related to oxygen and energy deficits, as well as diseases linked to PARP inhibition, particularly autoimmune and neurodegenerative diseases, viral diseases, and conditions caused by toxic effects.

Career Highlights

Throughout his career, Kalman Takacs has worked with prominent companies in the pharmaceutical industry, including Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. and Chinoin Pharmaceutical and Chemical Works Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in developing new pharmaceutical solutions.

Collaborations

Kalman has collaborated with notable colleagues such as Antal Simay and Ilona Kiss Nee Ajzert. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Kalman Takacs stands out as a significant figure in pharmaceutical innovation, with a focus on developing compounds that address critical health challenges. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…